Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We have recently demonstrated that the pyrazolopyrimidines PP1 and PP2 and the 4-anilinoquinazoline ZD6474 display a strong inhibitory activity (IC(50)< or =100 nM) towards constitutively active oncogenic RET kinases. Here, we show that most oncogenic MEN2-associated RET kinase mutants are highly susceptible to PP1, PP2 and ZD6474 inhibition. In contrast, MEN2-associated swap of bulky hydrophobic leucine or methionine residues for valine 804 in the RET kinase domain causes resistance to the three compounds. Substitution of valine 804 with the small amino- acid glycine renders the RET kinase even more susceptible to inhibition (ZD6474 IC(50): 20 nM) than the wild-type kinase. Our data identify valine 804 of RET as a structural determinant mediating resistance to pyrazolopyrimidines and 4-anilinoquinazolines.

Original publication

DOI

10.1038/sj.onc.1207810

Type

Journal article

Journal

Oncogene

Publication Date

12/08/2004

Volume

23

Pages

6056 - 6063

Keywords

Carcinoma, Medullary, Catalytic Domain, Cell Line, Drug Resistance, Enzyme Inhibitors, Mitogens, Piperidines, Point Mutation, Proto-Oncogene Proteins, Proto-Oncogene Proteins c-ret, Pyrazoles, Pyrimidines, Quinazolines, Receptor Protein-Tyrosine Kinases, Signal Transduction, Thyroid Neoplasms, Valine